Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05180838 · ClinicalTrials.gov registry record
Remote Temperature Data for Early Detection of Febrile Neutropenia
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 20
- Enrollment target
NCT05180838: Completed study, sponsored by University of Colorado, Denver.
NCT05180838 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05180838 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
BioSticker data is remotely tracked and displayed in a report termed the BioReport for retrospective data analysis. Typically, the biosensor collects data on an interval of \~1 minute and this data is collated and reported remotely back to the BioReport every 6 hours. More importantly, for future applications of the BioSticker for early detection of FN, there are ongoing efforts to implement real time reporting and alarms using remote monitoring services that could alert the patient that they need to seek medical care. There are no known deleterious effects from the BioSticker and it is now being widely used and tested in diverse applications including detection and contact tracing of COVID and others.
Primary Outcome
Patients will self-temperature check every 6 hours or at least two times per day, and will log these temperatures in a paper record with date, time and temperature noted.
Interventions
- DEVICE BioSticker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2024-03-31 |
What the finished NCT05180838 record still lists
NCT05180838 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which BioSticker is the first listed.
NCT05180838 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05180838 about?
NCT05180838 is a clinical study titled "Remote Temperature Data for Early Detection of Febrile Neutropenia". BioSticker data is remotely tracked and displayed in a report termed the BioReport for retrospective data analysis. Typically, the biosensor collects data on an interval of \~1 minute and this data is collated and reported remotely back to the BioReport every 6 hours. More importantly, for future ap...
What is the current status of trial NCT05180838?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-10-07. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT05180838?
The interventions under investigation include: BioSticker (DEVICE).
Who is sponsoring clinical trial NCT05180838?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI